Tao Capital Management LP
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 9, 2024), Tao Capital Management LP reported 10 stock positions worth $105.5 million. Its top holding was Madrigal Pharmaceuticals (MDGL) at 33.0% of the portfolio, followed by Twist Bioscience (TWST, 26.9%) and Tesla (TSLA, 14.4%). Compared with Q4 2023, it sold out of 2. The biggest sale was an exit from Denali Therapeutics (DNLI).
- Most Recent 13F
- Q2 2026
- Location
- SAN FRANCISCO, CA
- CIK
- 0001802967
- Portfolio Value
- $105.5M (Q1 2024)
- SEC Filing
- 0001802967-24-000004 ↗ filed May 9, 2024
Holdings Value
Holdings 10 stocks · $105.5M
| MDGL Madrigal Pharmaceuticals Inc. | 33.02% | 130,529 | $34.9M | No change |
| TWST Twist Bioscience Corp. | 26.94% | 828,815 | $28.4M | No change |
| TSLA Tesla Inc. | 14.37% | 86,250 | $15.2M | No change |
| H Hyatt Hotels Corp. Class A | 10.59% | 70,000 | $11.2M | No change |
| OUST Ouster Inc. | 8.47% | 1,125,316 | $8.9M | No change |
| MASS 908 Devices Inc. | 4.07% | 568,981 | $4.3M | No change |
| WRBY Warby Parker Inc. Class A | 1.73% | 134,473 | $1.8M | No change |
| BENSON HILL INC | 0.34% | 1,774,681 | $356K | No change |
| DNA Ginkgo Bioworks Holdings Inc. | 0.25% | 227,354 | $264K | No change |
| SONDQ Sonder Holdings Inc. | 0.22% | 80,188 | $237K | No change |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 6 | $1.9B | SPCX, TWST, TSLA, H, MDGL |
| Q1 2026 | 8 | $118.8M | TWST, TSLA, OUST, MDGL, H |
| Q4 2025 | 8 | $116.2M | TSLA, TWST, OUST, MDGL, H |
| Q3 2025 | 10 | $132.2M | TSLA, OUST, TWST, MDGL, H |
| Q2 2025 | 9 | $136.4M | MDGL, TWST, TSLA, OUST, H |
| Q1 2025 | 9 | $116.1M | MDGL, TWST, TSLA, OUST, H |
| Q4 2024 | 10 | $143.3M | MDGL, TWST, TSLA, OUST, H |
| Q3 2024 | 10 | $110.4M | TWST, MDGL, TSLA, H, OUST |
| Q2 2024 | 10 | $122.0M | TWST, MDGL, TSLA, OUST, H |
| Q1 2024 | 10 | $105.5M | MDGL, TWST, TSLA, H, OUST |